Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options
Int J Radiat Oncol Biol Phys
.
2023 Mar 1;115(3):545-552.
doi: 10.1016/j.ijrobp.2022.10.022.
Authors
Michael D Chuong
1
,
Christopher J Anker
2
,
Michael H Buckstein
3
,
Maria A Hawkins
4
,
Jordan Kharofa
5
,
Ann C Raldow
6
,
Nina N Sanford
7
,
Andrzej Wojcieszysnki
8
,
Jeffrey R Olsen
9
Affiliations
1
Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
2
Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.
3
Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
4
University College London, London, United Kingdom.
5
Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
6
Department of Radiation Oncology, University of California, Los Angeles, California.
7
Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas.
8
Kaiser Permanente Medical Group, Denver, Colorado.
9
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:
[email protected]
.
PMID:
36725162
DOI:
10.1016/j.ijrobp.2022.10.022
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Pancreas
Rectal Neoplasms* / radiotherapy